Ads
related to: journal of immunotherapy cancer if
Search results
Results From The WOW.Com Content Network
Cancer Immunology, Immunotherapy is a monthly peer-reviewed medical journal published by Springer Science+Business Media. According to the Journal Citation Reports , the journal has a 2020 impact factor of 6.968.
Cancer immunotherapy (immuno-oncotherapy) is the stimulation of the immune system to treat cancer, improving the immune system's natural ability to fight the disease. [1] It is an application of the fundamental research of cancer immunology ( immuno-oncology ) and a growing subspecialty of oncology .
Tumor-associated immune cells in the tumor microenvironment (TME) of breast cancer models. Cancer immunology (immuno-oncology) is an interdisciplinary branch of biology and a sub-discipline of immunology that is concerned with understanding the role of the immune system in the progression and development of cancer; the most well known application is cancer immunotherapy, which utilises the ...
Immunotherapy or biological therapy is the treatment of disease by activating or suppressing the immune system.Immunotherapy is designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.
Cancer Immunology Research is a monthly peer-reviewed medical journal published by the American Association for Cancer Research. It covers research and clinical trials related to the study of cancer immunology. The editors-in-chief are Robert D. Schreiber and Philip Greenberg. [1] The journal was established in 2013. [1]
Immunotherapy is a peer-reviewed medical journal covering immunology and more specifically immunotherapy. It was established in 2009 and is published by Future Medicine. The founding editor-in-chief was Duc Hong Le. The current editors-in-chief are Y. Kawakami, F.M. Marincola, K. Tsang and D.C. Wraith.
The Society for Immunotherapy of Cancer (SITC), previously known as the International Society for Biological Therapy of Cancer (iSBTc), is a professional society of scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving outcomes in patients with cancer by advancing the science and application of cancer ...
Checkpoint inhibitor therapy is a form of cancer immunotherapy. The therapy targets immune checkpoints , key regulators of the immune system that when stimulated can dampen the immune response to an immunologic stimulus.